Holen Sie sich die Stockscreener-App
1.2701
5.88%
0.0801
Schlusskurs vom Vortag:
$1.19
Offen:
$1.23
24-Stunden-Volumen:
101.34K
Relative Volume:
0.10
Marktkapitalisierung:
$1.68M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.90M
KGV:
-0.00529
EPS:
-239.88
Netto-Cashflow:
$-12.75M
1W Leistung:
-10.64%
1M Leistung:
-22.70%
6M Leistung:
+117.50%
1J Leistung:
-87.65%
1-Tages-Spanne:
$1.20
$1.28
1-Wochen-Bereich:
$1.15
$1.40
52-Wochen-Spanne:
$0.1131
$22.20
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Firmenname
Allarity Therapeutics Inc
Sektor
Branche
Telefon
401-426-4664
Adresse
24 SCHOOL ST., 2ND FLOOR, BOSTON
Vergleichen Sie ALLR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ALLR | 1.28 | 1.68M | 0 | -11.90M | -12.75M | -239.88 |
| VRTX | 450.44 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.45 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.18 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.35 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.90 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Allarity Therapeutics Inc Aktie (ALLR) Neueste Nachrichten
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements - GlobeNewswire
Allarity's Phase 2 Cancer Drug Shows Promise: Patients Exceed 14-Month Treatment | ALLR Stock News - StockTitan
Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights - The Manila Times
Allarity Therapeutics Reports $18.5M Cash Position, Extended Runway in Q3 Results | ALLR Stock News - StockTitan
FINAL REMINDER ALLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Allarity Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit! - AccessWire
DEADLINE ALERT for ALLR, and COIN: The Law Offices of Frank - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - Business Wire
FINAL ALLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Allarity Therapeutics, Inc. Investors to Join the Class Action Lawsuit! - AccessWire
ALLR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire
ALLR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. - The Bakersfield Californian
ALLR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALLR - GlobeNewswire Inc.
ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Allarity Therapeutics, Inc. (ALLR) - Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - PR Newswire
ALLR Deadline: ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit - GuruFocus.com
ALLR FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages - GlobeNewswire
ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit - cnhinews.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - GlobeNewswire
ALLARITY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Allarity Therapeutics, Inc. and Encourages Investors to Contact the Firm - ForexTV.com
ALLARITY ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Lawsuit filed for Investors who lost money with shares of Allarity Therapeutics, Inc. (NASDAQ: ALLR) - openPR
Glancy Prongay & Murray LLP Reminds Investors of Looming - GlobeNewswire
DEADLINE ALERT for WBTN, GTLB, ALLR, and COIN: The Law - GlobeNewswire
ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
ALLR 截止日期通知：全球領先的律師事務所 ROSEN 鼓勵 Allarity Therapeutics, Inc. 投資者在證券集體訴訟的重要截止日期 11 月 12 日 之前聘請律師 - GlobeNewswire Inc.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allarity Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesALLR - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors - GlobeNewswire
ALLR DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire
Allr Deadline Notice: Rosen, A Global And Leading Law Firm, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – ALLR - Wahanariau
ALLR Investors Have Opportunity to Lead Allarity Therapeutics, I - GuruFocus.com
Allarity Therapeutics stock hits 52-week low at $1.32 amid steep decline - Investing.com Australia
Allarity Therapeutics stock hits 52-week low at $1.32 amid steep decline By Investing.com - Investing.com South Africa
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ALLR FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire
Allarity Therapeutics, Inc. Investors: Please contact the - GlobeNewswire
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Finanzdaten der Allarity Therapeutics Inc-Aktie (ALLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):